ibuprofen · Mcneil Consumer · NDA 017463, 019842, 020135, 020418, 020476

Motrin

Earliest generic entry, as listed · earliest of 5 marketed strengths
Open now

No marketed reference-listed strength; date taken from all listed strengths.

No unexpired patents or exclusivities are listed for this product.

Listed patents · 0 unexpired

No unexpired patents listed.

Exclusivities · 0 unexpired

No unexpired exclusivities listed.

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

  • Generic approved · ANDA 220239, Rubicon Research · 019842-001Approved 5 Mar 2026Detected 25 Oct 2026Historical import

Products covered · 9

NDA · productFormStrengthListed expiry
017463 · 002 · RLD · discontinuedtablet, oral400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
017463 · 003 · RLD · discontinuedtablet, oral300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
017463 · 004 · RLD · discontinuedtablet, oral600MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
017463 · 005 · RLD · discontinuedtablet, oral800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
019842 · 001 · RLD · discontinuedsuspension, oral100MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
020135 · 001 · discontinuedtablet, chewable, oral50MGopen
020135 · 002 · discontinuedtablet, chewable, oral100MGopen
020418 · 001 · discontinuedtablet, oral100MGopen
020476 · 001 · discontinuedsuspension/drops, oral40MG/MLopen